Immy Wins $1.5M NIH Contract for Point-of-Care Talaromycosis Test
Talaromycosis is an infection caused by airborne inhalation of the fungus Talaromyces marneffei and is endemic in Southeast Asia.
Pathonostics Gets CE Mark for Next-Gen Test for Fungal Skin Infections
The multiplex PCR test can detect and distinguish more than 15 fungal pathogens that cause dermatophytosis.
BGI Bloodstream Pathogen Nucleic Acid Detection Kit Gets CE Mark
The kit, developed by BGI Patho-Genesis Pharmaceutical Technology, is designed to construct a metagenomic sequencing library directly from clinical samples.
Two new grants are helping the company develop its SHERLOCK and INSPECTR technologies as the basis for creating innovative diagnostics.
The Branford, Connecticut-based startup plans to seek US Food and Drug Administration clearance for and launch its instrument and first assays in 2021.
Jan 25, 2019
Jul 30, 2018
GenMark Diagnostics Q2 Revenues Rise 20 Percent
Dec 6, 2017
FDA Clears DxNA's Valley Fever Molecular Test
Dec 6, 2017
Oct 18, 2017
Jul 18, 2017
T2 Biosystems Receives CE Mark for Bacterial Panel
Feb 28, 2017
Nov 3, 2016
GenMark Diagnostics Q3 Revenues Up 28 Percent
Sep 20, 2016
Aug 26, 2016